Search results for "Smoking"

showing 10 items of 641 documents

Which is the best communication strategy, based on anti-tobacco ads, to impress teenagers? A multicenter cross-sectional study

2020

Background. Well-planned mass-media campaigns can increase health literacy and raise awareness about the consequences of tobacco use. This study aims to evaluate the emotions and opinions of adolescents about several anti-tobacco spots delivered by the mass media over the world. Study design. Cross-sectional study. Methods. The study was conducted in Italy in 2016–2017 among students aged 13–17 years. Students expressed their emotions and opinions about seven anti-tobacco spots from all over the world on different topics and styles. Results. 499 students attended. The video “Sponge” was found to be the most impressive (30.2%) and what they would have chosen if they had been responsible for …

Cross-Sectional StudieAdolescents; anti-tobacco ads; emotions; mass media campaign; opinions; Adolescent; Advertising; Communication; Cross-Sectional Studies; Humans; Tobacco Use; Smoking Prevention; TobaccoopinionsAdolescentCommunicationopinionemotionSmoking PreventionSettore MED/42 - Igiene Generale E ApplicataAdolescentsemotionsTobacco UseCross-Sectional StudiesAdvertisingTobaccoanti-tobacco adHumansmass media campaignHumananti-tobacco ads
researchProduct

Tobacco smoking prevalence in pregnant women: metanalysis of cross sectional studies

2020

Abstract Background Notwithstanding tobacco smoking during pregnancy is associated with negative health outcomes, its prevalence was not included by worldwide surveillance system. The main objective was to estimate the number of women who had smoked at least one cigarette during her pregnancy in comparison to not smoking women. Methods A systematic review and metanalysis was conducted searching on MEDLINE, Pubmed and Scopus on the 2 January 2020. Keywords were searched with English language limits from 2017 to 2019. Three authors independently screened all titles and abstracts applying the inclusion criteria, extracted the data, filled a database and two other authors assessed doubt eligibi…

Cross-sectional studybusiness.industryEnvironmental healthPublic Health Environmental and Occupational HealthMedicineSmoking prevalencebusinessEuropean Journal of Public Health
researchProduct

Carbocysteine regulates innate immune responses and senescence processes in cigarette smoke stimulated bronchial epithelial cells

2013

Cigarette smoke represents the major risk factor for chronic obstructive pulmonary disease (COPD). Cigarette smoke extracts (CSE) alter TLR4 expression and activation in bronchial epithelial cells. Carbocysteine, an anti-oxidant and mucolytic agent, is effective in reducing the severity and the rate of exacerbations in COPD patients. The effects of carbocysteine on TLR4 expression and on the TLR4 activation downstream events are largely unknown. This study was aimed to explore whether carbocysteine, in a human bronchial epithelial cell line (16-HBE), counteracted some pro-inflammatory CSE-mediated effects. In particular, TLR4 expression, LPS binding, p21 (a senescence marker), IL-8 mRNA and…

Cyclin-Dependent Kinase Inhibitor p21AgingNeutrophilsPhalloidinAnti-Inflammatory AgentsApoptosisBronchiInflammationBiologyToxicologySettore BIO/09 - FisiologiaAntioxidantsFlow cytometryPulmonary Disease Chronic Obstructivechemistry.chemical_compoundmedicineHumansRNA Messengersenescencebronchial cellscigaretteInnate immune systemmedicine.diagnostic_testCarbocysteineInterleukin-8SmokingEpithelial CellsCell migrationChemotaxisCarbocysteineGeneral MedicineFlow CytometryImmunity InnateCell biologyToll-Like Receptor 4chemistryImmunologyTLR4medicine.symptomInterleukin-1Signal TransductionToxicology Letters
researchProduct

Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist

2015

Chronic obstructive pulmonary disease (COPD) is characterised by chronic pulmonary inflammation punctuated by periods of viral exacerbations. Recent evidence suggests that the combination of roflumilast with corticosteroids may improve the compromised anti-inflammatory properties of corticosteroids in COPD. We analyzed differential and combination anti-inflammatory effects of dexamethasone and roflumilast N-oxide in human bronchial epithelial cells (HBECs) stimulated with viral toll like receptor (TLR) agonists. Lung tissue and HBECs were isolated from healthy (n = 15), smokers (n = 12) and smokers with COPD (15). TLR3 expression was measured in lung tissue and in HBECs. IL-8 secretion was …

CyclopropanesMaleAnti-Inflammatory AgentsDrug ResistanceAminopyridinesDexamethasonePulmonary Disease Chronic ObstructiveRoflimilastAdrenal Cortex HormonesToll like receptorsCells CulturedCOPDSmokingMiddle Agedmedicine.anatomical_structureBenzamidesCorticosteroidViral exacerbationDrug Therapy CombinationFemalePulmones - Enfermedadesmedicine.drugSignal TransductionAgonistPulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.drug_classCorticosteroid resistanceBronchiInternal medicinemedicineCOPDHumansInterleukin 8DexamethasoneRoflumilastAgedLungbusiness.industryResearchInterleukin-8Epithelial CellsAparato respiratoriomedicine.diseaserespiratory tract diseasesToll-Like Receptor 3EndocrinologyPoly I-CCase-Control StudiesTLR3businessRespiratory Research
researchProduct

Predictors of smoking cessation among smokers with cardiovascular diseases and risks factors in the French smoking cessation services national databa…

2022

Background: Smoking represents a major modifiable risk factor for cardiovascular diseases (CVD), particularly in women. The smoking prevalence in France is among the highest in Europe, and the identification of factors associated with smoking cessation in high-risk CV populations remains poorly studied, specifically when potential sex-disparities might exist. The objective of this work was firstly to describe the current state of knowledge on the association between tobacco consumption and CVD risk in women, through a literature review. Then, using the French national smoking cessation consultations database - CDTnet, to describe the socio-demographic profile, medical profile and smoking be…

DatabaseCardiovascular diseases[SDV.OT] Life Sciences [q-bio]/Other [q-bio.OT]TabacFemmeSmokingBase de donnéesWomenSmoking cessationSevrage tabagiqueFacteurs de risque cardiovasculaireCardiovascular risk factorsMaladies cardiovasculaires
researchProduct

Smoking ban in public places and myocardial infarction hospitalizations in high cardiovascular risk European country – insights from the Polish natio…

2019

Introduction Previous studies demonstrated a possible positive effect of a smoking ban in public places on cardiovascular outcomes. However, little is known about the influence of such regulations in Poland, a country with a high cardiovascular risk. Objectives We aimed to evaluate the association of hospitalization rates for acute myocardial infarction (AMI) in Poland before and after the introduction of the smoking ban in public places in November 2010. Patients and methods The Nationwide Acute Myocardial Infarction Database (AMI‑PL) was searched for the cases of AMI that occurred between 2009 and 2014. The analysis considered sex, age (20-64 years vs 65 years or older), and the place of …

Databasebusiness.industryIncidence (epidemiology)05 social sciences030204 cardiovascular system & hematologycomputer.software_genremedicine.disease03 medical and health sciences0302 clinical medicineOlder patientsAge groups0502 economics and businessInternal MedicineMedicine050211 marketingResidenceMyocardial infarctionSmoking banYoung adultbusinessCardiovascular outcomescomputerPolish Archives of Internal Medicine
researchProduct

Factors associated with early recurrence at the first evaluation of patients with transient ischemic attack.

2014

Abstract We aimed to identify factors easily collected at admission in patients with transient ischemic attack (TIA) that were associated with early recurrence, so as to guide clinicians’ decision-making about hospitalization in routine practice. From September 2011 to January 2013, all TIA patients who were referred to the University Hospital of Dijon, France, were identified. Vascular risk factors and clinical information were collected. The etiology of the TIA was defined according to the results of complementary examinations performed at admission as follows: large artery atherosclerosis (LAA-TIA) TIA, TIA due to atrial fibrillation (AF-TIA), other causes, and undetermined TIA. Logistic…

Diagnostic ImagingMalemedicine.medical_specialtyEarly RecurrenceHypercholesterolemiaCoronary DiseaseLogistic regressionPatient AdmissionRecurrenceRisk FactorsPhysiology (medical)Internal medicineparasitic diseasesEpidemiologyAtrial FibrillationmedicineDiabetes MellitusHumanscardiovascular diseasesStrokeAgedAged 80 and overbusiness.industrySmokingAtrial fibrillationCardiovascular AgentsGeneral MedicineOdds ratioLength of StayMiddle Agedmedicine.diseaseAtherosclerosisConfidence intervalnervous system diseasesSurgeryNeurologyIschemic Attack TransientHypertensionEtiologySurgeryFemaleNeurology (clinical)FranceEmergenciesbusinessJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
researchProduct

Response to Agomelatine Treatment is Independent of Smoking Status and Dosage: Results From the AGOPSYCH Study.

2018

Abstract Introduction Cigarette smoking influences response to antidepressant treatment. It accelerates the metabolism of several cytochrome P450 (CYP) subtypes, including CYP1A2, and therefore bears the risk of pharmacokinetic interactions with psychotropic drugs using that pathway. Agomelatine is a substrate of CYP1A2; the association between nicotine use and agomelatine dosage, however, has never been studied before. Methods Smoking habits were correlated with agomelatine doses and treatment outcomes in a sample of 27 patients with lifetime diagnoses within the schizophrenia spectrum who received agomelatine treatment in addition to their stable antipsychotic treatment regimen because of…

DrugOncologyAdultMalemedicine.medical_specialtymedia_common.quotation_subject030226 pharmacology & pharmacyNicotine03 medical and health sciencesYoung Adult0302 clinical medicinePharmacokineticsInternal medicineAcetamidesmedicineAgomelatineHumansPharmacology (medical)Young adultmedia_commonPsychiatric Status Rating ScalesDose-Response Relationship Drugbusiness.industryDepressionSmokingGeneral MedicineMiddle Agedmedicine.diseaseAntidepressive Agents030227 psychiatry3. Good healthPsychiatry and Mental healthRegimenTreatment OutcomeSchizophreniaAntidepressantFemalebusinessmedicine.drugPharmacopsychiatry
researchProduct

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European…

2016

AIMS: To determine whether the Joint European Societies guidelines on cardiovascular prevention are being followed in everyday clinical practice of secondary prevention and to describe the lifestyle, risk factor and therapeutic management of coronary patients across Europe. METHODS AND RESULTS: EUROASPIRE IV was a cross-sectional study undertaken at 78 centres from 24 European countries. Patients <80 years with coronary disease who had coronary artery bypass graft, percutaneous coronary intervention or an acute coronary syndrome were identified from hospital records and interviewed and examined ≥ 6 months later. A total of 16,426 medical records were reviewed and 7998 patients (24.4% female…

EUROASPIRE InvestigatorsMaleCardiac & Cardiovascular SystemsTime FactorsEpidemiologyCARDIOVASCULAR-DISEASE PREVENTIONCoronary DiseaseComorbidity030204 cardiovascular system & hematologyOverweightlaw.invention0302 clinical medicineRandomized controlled triallawRisk FactorsPrevalenceSecondary PreventionARTERY-DISEASE030212 general & internal medicineEUROASPIREguidelinesProspective StudiesPractice Patterns Physicians'Societies MedicalSecondary preventionGLUCOSE REGULATIONSmokingcardiovascular preventionRANDOMIZED CONTROLLED-TRIALMiddle AgedClinical PracticeEuropeTreatment OutcomePractice Guidelines as TopicCardiologyLDL Cholesterol LipoproteinsFemaleGuideline Adherencemedicine.symptomCardiology and Cardiovascular MedicineLife Sciences & BiomedicineAdultmedicine.medical_specialtyAdolescentCardiologyHEART-DISEASERisk Assessmentrehabilitation03 medical and health sciencesYoung AdultCardiovascular preventionSDG 3 - Good Health and Well-beingInternal medicinemedicineHumansRisk factorCARDIAC REHABILITATIONExerciseAgedScience & TechnologyTask forcebusiness.industryCardiovascular AgentsDietCross-Sectional StudiesMYOCARDIAL-INFARCTIONCLINICAL-PRACTICEHealth Care SurveysCardiovascular System & CardiologySmoking CessationSedentary BehaviorbusinessRisk Reduction BehaviorTASK-FORCEEuropean journal of preventive cardiology
researchProduct

Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD.

2014

Background In models of COPD, environmental stressors induce innate immune responses, inflammasome activation and inflammation. However, the interaction between these responses and their role in driving pulmonary inflammation in stable COPD is unknown. Objectives To investigate the activation of innate immunity and inflammasome pathways in the bronchial mucosa and bronchoalveolar lavage (BAL) of patients with stable COPD of different severity and control healthy smokers and non-smokers. Methods Innate immune mediators (interleukin (IL)-6, IL-7, IL-10, IL-27, IL-37, thymic stromal lymphopoietin (TSLP), interferon γ and their receptors, STAT1 and pSTAT1) and inflammasome components (NLRP3, NA…

EXPRESSIONMaleINTERLEUKIN-6InflammasomesCOPD PathologyChronic Obstructive Pulmonary DiseaseRespiratory SystemImmunity NLRP3 COPDBronchiReceptors Cell SurfaceRespiratory MucosaPULMONARYInterferon-gammaPulmonary Disease Chronic ObstructiveMARKERSThymic Stromal LymphopoietinSPUTUMNLR Family Pyrin Domain-Containing 3 ProteinCytokine Receptor gp130Humans1506HMGB1 ProteinAdaptor Proteins Signal TransducingAgedScience & TechnologyRECEPTORInterleukinsSmoking1103 Clinical SciencesMiddle AgedInterleukin-1 Receptor-Like 1 ProteinImmunity InnateInnate Immunityrespiratory tract diseasesANTIINFLAMMATORY CYTOKINESTAT1 Transcription FactorCase-Control StudiesT-CELLSASTHMACytokinesFemaleCOPD Pathology Innate ImmunityCarrier ProteinsLife Sciences & BiomedicineBronchoalveolar Lavage FluidSMOKERSThorax
researchProduct